Search Results 141-150 of 22747 for B cell lymphomas

  1. Bone Marrow Transplant Program - Doctors - Mayo Clinic

    Bone marrow transplant, CAR-T cell therapy, B-cell lymphoma, Waldenstrom macroglobulinemia, Non-Hodgkin lymphoma, Folli...cular lymphoma, Hodgkin lymphoma.

  2. Preparing to biomanufacture a new CAR-T cell therapy for B-cell cancers - Mayo Clinic News Network

    ... B-cell lymphomas and leukemias into remission. However, leukemia and lymphoma tumors can change over time and become resistant to therapies, resulting in a ...

  3. Patrizia Mondello, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Most B-cell lymphomas are caused by changes in transcription factors and chromatin modifier genes. Transcription factors affect genetic information. Dr.

  4. Hodgkin Clinical Trials - Mayo Clinic Research

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer ... B-cell lymphomas. Clinically, four weekly doses of rituximab have proven to ...

  5. A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/​r B-NHL) - Mayo Clinic

    The goal of this multicenter study is to test JNJ-90009530 in Relapsed or Refractory Non-Hodgkin Lymphoma Patients. The main questions the study aims to answer ...

  6. Lymphoma - Survival rates - Mayo Clinic

    Incorporation of digital gene expression profiling for cell-of-origin determination (Lymph2Cx Testing) into the routine work-up of diffuse large B-cell lymphoma ...

  7. Small lymphocytic lymphoma - Survival rates - Mayo Clinic

    Chronic lymphocytic leukemia/small lymphocytic lymphoma, monoclonal B-cell lymphocytosis, and B-cell prolymphocytic leukemia. In: Hematopathology. 3rd ed ...

  8. Publications - Patrick B. Johnston, M.D., Ph.D. - Mayo Clinic

    ... Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas. ... cell therapy for large B-cell lymphoma: the Mayo Clinic experience. Leuk ...

  9. A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · Overview.

  10. Primary CNS Lymphoma Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine how well nivolumab with or without varlilumab works in treating patients with aggressive B-cell lymphomas that have ...